Aspergillus sp. isolated in critically ill patients with extracorporeal membrane oxygenation support

Scandinavian Journal of Infectious Diseases

Volumn 45, Issue 9, 2013, Pages 715-721

  Aubron, Cecile ^a,b   Pilcher, David ^a,b   Leong, Tim ^a,b   Cooper, D James ^a,b   Scheinkestel, Carlos ^a,b   Pellegrino, Vince ^a,b   Cheng, Allen C ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Aspergillus sp.; Critically ill patients; Extracorporeal membrane oxygenation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASPERGILLUS; COHORT ANALYSIS; CRITICALLY ILL PATIENT; EXTRACORPOREAL OXYGENATION; FEMALE; FUNGAL COLONIZATION; FUNGUS ISOLATION; HUMAN; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; ASPERGILLOSIS; ASPERGILLUS; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84882446233     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2013.797598     Document Type: Article

References (23)

1. Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F, et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients . Crit Care 2006; 10: R31
2. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, Leon C, Alvarez-Lerma F, Nolla-Salas J, et al . Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: Risk factors, clinical presentation and outcome . Crit Care 2005; 9: R191-9
3. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E . Invasive aspergillosis in critically ill patients without malignancy . Am J Respir Crit Care Med 2004; 170: 621-5 (Pubitemid 39202203)
4. Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent JL . Disseminated aspergillosis in intensive care unit patients: An autopsy study . JChemother 2003; 15: 71-5 (Pubitemid 36349895)
5. Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, et al . Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America . Clin Infect Dis 2000; 30: 696-709
6. De Pauw B, Walsh T J, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al . Revised defi nitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group . Clin Infect Dis 2008; 46: 1813-21
7. Ascioglu S, Rex J H, de Pauw B, Bennett J E, Bille J, Crokaert F, et al . Defi ning opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus . Clin Infect Dis 2002; 34: 7-14 (Pubitemid 33152659)
8. Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, et al . Galactomannan in bronchoalveolar lavage fl uid: A tool for diagnosing aspergillosis in intensive care unit patients . Am J Respir Crit Care Med 2008; 177: 27-34
9. Blot S I, Taccone F S, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, et al . Aclinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients . Am J Respir Crit Care Med 2012; 186: 56-64
10. Khasawneh F, Mohamad T, Moughrabieh MK, Lai Z, Ager J, Soubani AO . Isolation of Aspergillus in critically ill patients: A potential marker of poor outcome . JCrit Care 2006; 21: 322-7 (Pubitemid 44908866)
11. Vandewoude KH, Blot SI, Benoit D, Colardyn F, Vogelaers D . Invasive aspergillosis in critically ill patients: Attributable mortality and excesses in length of ICU stay and ventilator dependence . JHospital Infect 2004; 56: 269-76 (Pubitemid 38444078)
12. M arasco SF, Lukas G, McDonald M, McMillan J, Ihle B. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients . Heart Lung Circ 2008; 17(Suppl 4): S41-7
13. Brogan T V, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL . Extracorporeal membrane oxygenation in adults with severe respiratory failure: A multi-center database. Intensive Care Med 2009; 35: 2105-14
14. O' N eill JM, Schutze GE, Heulitt MJ, Simpson PM, Taylor BJ . Nosocomial infections during extracorporeal membrane oxygenation . Intensive Care Med 2001; 27: 1247-53
15. Burket JS, Bartlett RH, Vander Hyde K, Chenoweth CE. Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation . Clin Infect Dis 1999; 28: 828-33 (Pubitemid 29169423)
16. Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P, Org EL. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults . Pediatr Crit Care Med 2011; 12: 277-81
17. Aubron C, Cheng AC, Pilcher D, Leong T, Magrin G, Cooper DJ, et al . Infections acquired by adults who receive extracorporeal membrane oxygenation: Risk factors and outcome . Infect Control Hosp Epidemiol 2013; 34: 24-30
18. Schutze G E, Heulitt M J . Infections during extracorporeal life support . JPediatr Surg 1995; 30: 809-12
19. Garcia X, Mian A, Mendiratta P, Gupta P, Rycus P, Prodhan P . Aspergillus infection and extracorporeal membrane oxygenation support . JIntensive Care Med 2013; 28: 178-84
20. Knaus W A, Draper E A, Wagner D P, Zimmerman J E. APACHE II: A severity of disease classifi cation system . Crit Care Med 1985; 13: 818-29 (Pubitemid 15250137)
21. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure . On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine . Intensive Care Med 1996; 22: 707-10
22. Patterson T F, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, et al . Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes . I3 Aspergillus Study Group . Medicine (Baltimore) 2000; 79: 250-60
23. Spriet I, Annaert P, Meersseman P, Hermans G, Meersseman W, Verbesselt R, et al . Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation . JAntimicrob Chemother 2009; 63: 767-70